Ropivacaine
- Generic Name
- Ropivacaine
- Brand Names
- Naropin
- Drug Type
- Small Molecule
- Chemical Formula
- C17H26N2O
- CAS Number
- 84057-95-4
- Unique Ingredient Identifier
- 7IO5LYA57N
- Background
Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
- Indication
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
- Associated Conditions
- Acute Pain, Postoperative pain
- Associated Therapies
- Surgical anesthesia therapy
Regional TAP Block for Bariatric Patients
- Conditions
- Interventions
- First Posted Date
- 2019-08-09
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 23
- Registration Number
- NCT04051684
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Axillary Block in Association With Analgesic Truncal Blocks at the Elbow for Wrist Surgery.
- Conditions
- Interventions
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- CMC Ambroise Paré
- Target Recruit Count
- 150
- Registration Number
- NCT04046744
- Locations
- 🇫🇷
Clinique du Pré, Le Mans, Pays De La Loire, France
🇫🇷Clinique Bizet, Paris, Ile-de -France, France
🇫🇷CMC Ambroise Paré, Neuilly-sur-Seine, Ile-de-France, France
The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane in Total Shoulder Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 17
- Registration Number
- NCT04020601
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
The PATHFINDER Study: A Feasibility Trial
- Conditions
- Interventions
- First Posted Date
- 2019-07-11
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT04016740
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour
- Conditions
- Interventions
- First Posted Date
- 2019-07-08
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- KK Women's and Children's Hospital
- Target Recruit Count
- 216
- Registration Number
- NCT04011150
- Locations
- 🇸🇬
KK Women's and Children's Hospital, Singapore, Singapore
Chronic Pain and Functional Prognosis After Total Knee Replacement: Continuous Locoregional Analgesia by Catheter to the Femoral Triangle Versus Tissue Infiltration as Part of an Improved Rehabilitation After Surgery Approach
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- Centre Hospitalier Departemental Vendee
- Target Recruit Count
- 287
- Registration Number
- NCT03998813
- Locations
- 🇫🇷
Clinique Victor PAUCHET, Amiens, France
🇫🇷Centre Hospitalier de Béthune Beuvry, Béthune, France
🇫🇷Hôpital Privé Sévigné, Rennes, France
The Effect of Epidural Steroid Use in Patients With Continous Epidural Block in PHN Patients.
- First Posted Date
- 2019-06-24
- Last Posted Date
- 2019-06-24
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03995563
- Locations
- 🇰🇷
Kangnam sacred heart hospital, Seoul, Yeongdeungpo-gu, Korea, Republic of
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Yale University
- Target Recruit Count
- 192
- Registration Number
- NCT03977454
- Locations
- 🇺🇸
Yale-New Haven Hospital St Raphael, New Haven, Connecticut, United States
Systemic Effects of Lidocaine Infusion for TAP Block Catheter
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 80
- Registration Number
- NCT03971708
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture
- Conditions
- Interventions
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2020-02-27
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Registration Number
- NCT03955458
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.